Dihydropyridine Lactam Analogs Targeting BET Bromodomains.

Jiang J, Sigua LH, Chan A, Kalra P, Pomerantz WCK, Schönbrunn E, Qi J, Georg GI

DOI: 10.1002/cmdc.202100407
Published: 2022 Jan 5
Container: ChemMedChem
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cmdc.202100407,
  title = {Dihydropyridine Lactam Analogs Targeting BET Bromodomains.},
  author = {Jiang J and Sigua LH and Chan A and Kalra P and Pomerantz WCK and Schönbrunn E and Qi J and Georg GI},
  year = {2022},
  journal = {ChemMedChem},
  doi = {10.1002/cmdc.202100407},
  url = {https://doi.org/10.1002/cmdc.202100407}
}

RIS

TY  - JOUR
TI  - Dihydropyridine Lactam Analogs Targeting BET Bromodomains.
AU  - Jiang J
AU  - Sigua LH
AU  - Chan A
AU  - Kalra P
AU  - Pomerantz WCK
AU  - Schönbrunn E
AU  - Qi J
AU  - Georg GI
PY  - 2022
JO  - ChemMedChem
DO  - 10.1002/cmdc.202100407
UR  - https://doi.org/10.1002/cmdc.202100407
ER  -

APA

J, J., LH, S., A, C., P, K., WCK, P., E, S., J, Q., & GI, G. (2022). Dihydropyridine Lactam Analogs Targeting BET Bromodomains.. ChemMedChem. https://doi.org/10.1002/cmdc.202100407

Source records

pubmed · retrieved 2026-09-25T13:36:15.570Z